795 related articles for article (PubMed ID: 33273553)
1. Non-epigenetic induction of HEXIM1 by DNMT1 inhibitors and functional relevance.
Sharma V; Montano MM
Sci Rep; 2020 Dec; 10(1):21015. PubMed ID: 33273553
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of DNMT1 and ERRα crosstalk suppresses breast cancer via derepression of IRF4.
Vernier M; McGuirk S; Dufour CR; Wan L; Audet-Walsh E; St-Pierre J; Giguère V
Oncogene; 2020 Oct; 39(41):6406-6420. PubMed ID: 32855526
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B.
Palii SS; Van Emburgh BO; Sankpal UT; Brown KD; Robertson KD
Mol Cell Biol; 2008 Jan; 28(2):752-71. PubMed ID: 17991895
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the histone demethylase, KDM5B, directly induces re-expression of tumor suppressor protein HEXIM1 in cancer cells.
Montano MM; Yeh IJ; Chen Y; Hernandez C; Kiselar JG; de la Fuente M; Lawes AM; Nieman MT; Kiser PD; Jacobberger J; Exner AA; Lawes MC
Breast Cancer Res; 2019 Dec; 21(1):138. PubMed ID: 31805991
[TBL] [Abstract][Full Text] [Related]
5. The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells.
Hsi LC; Xi X; Wu Y; Lippman SM
Mol Cancer Ther; 2005 Nov; 4(11):1740-6. PubMed ID: 16275995
[TBL] [Abstract][Full Text] [Related]
6. Induction of HEXIM1 activities by HMBA derivative 4a1: Functional consequences and mechanism.
Ketchart W; Yeh IJ; Zhou H; Thiagarajan PS; Lathia J; Reizes O; Exner A; Su B; Montano MM
Cancer Lett; 2016 Aug; 379(1):60-9. PubMed ID: 27238569
[TBL] [Abstract][Full Text] [Related]
7. HEXIM1 regulates 17beta-estradiol/estrogen receptor-alpha-mediated expression of cyclin D1 in mammary cells via modulation of P-TEFb.
Ogba N; Chaplin LJ; Doughman YQ; Fujinaga K; Montano MM
Cancer Res; 2008 Sep; 68(17):7015-24. PubMed ID: 18757415
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Anti-Cancer Treatment With a Stabilized Carbocyclic Decitabine Analogue.
Traube FR; Brás NF; Roos WP; Sommermann CC; Diehl T; Mayer RJ; Ofial AR; Müller M; Zipse H; Carell T
Chemistry; 2022 May; 28(26):e202200640. PubMed ID: 35285586
[TBL] [Abstract][Full Text] [Related]
9. The frequency of CpG and non-CpG methylation of Notch3 gene promoter determines its expression levels in breast cancer cells.
Xiao W; Liu X; Niu X; Li C; Guo Y; Tan J; Xiong W; Fan L; Li Y
Exp Cell Res; 2020 Jan; 386(2):111743. PubMed ID: 31770532
[TBL] [Abstract][Full Text] [Related]
10. Identification of HEXIM1 as a positive regulator of p53.
Lew QJ; Chia YL; Chu KL; Lam YT; Gurumurthy M; Xu S; Lam KP; Cheong N; Chao SH
J Biol Chem; 2012 Oct; 287(43):36443-54. PubMed ID: 22948151
[TBL] [Abstract][Full Text] [Related]
11. Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.
Lin HY; Kuo YC; Weng YI; Lai IL; Huang TH; Lin SP; Niu DM; Chen CS
Prostate; 2012 Dec; 72(16):1767-78. PubMed ID: 22539223
[TBL] [Abstract][Full Text] [Related]
12. The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2'-deoxycytidine lesions.
Orta ML; Höglund A; Calderón-Montaño JM; Domínguez I; Burgos-Morón E; Visnes T; Pastor N; Ström C; López-lázaro M; Helleday T
Nucleic Acids Res; 2014 Aug; 42(14):9108-20. PubMed ID: 25074383
[TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines.
Yan L; Nass SJ; Smith D; Nelson WG; Herman JG; Davidson NE
Cancer Biol Ther; 2003; 2(5):552-6. PubMed ID: 14614325
[TBL] [Abstract][Full Text] [Related]
14. 5-aza-2'-deoxycytidine has minor effects on differentiation in human thyroid cancer cell lines, but modulates genes that are involved in adaptation in vitro.
Dom G; Galdo VC; Tarabichi M; Tomás G; Hébrant A; Andry G; De Martelar V; Libert F; Leteurtre E; Dumont JE; Maenhaut C; van Staveren WC
Thyroid; 2013 Mar; 23(3):317-28. PubMed ID: 23167291
[TBL] [Abstract][Full Text] [Related]
15. Suppression of NF-kappaB-dependent gene expression by a hexamethylene bisacetamide-inducible protein HEXIM1 in human vascular smooth muscle cells.
Ouchida R; Kusuhara M; Shimizu N; Hisada T; Makino Y; Morimoto C; Handa H; Ohsuzu F; Tanaka H
Genes Cells; 2003 Feb; 8(2):95-107. PubMed ID: 12581153
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy.
Zhang MY; Calin GA; Yuen KS; Jin DY; Chim CS
Clin Epigenetics; 2020 Oct; 12(1):150. PubMed ID: 33076962
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA.
Yik JH; Chen R; Nishimura R; Jennings JL; Link AJ; Zhou Q
Mol Cell; 2003 Oct; 12(4):971-82. PubMed ID: 14580347
[TBL] [Abstract][Full Text] [Related]
18. HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription.
Contreras X; Barboric M; Lenasi T; Peterlin BM
PLoS Pathog; 2007 Oct; 3(10):1459-69. PubMed ID: 17937499
[TBL] [Abstract][Full Text] [Related]
19. Comparison of DNMT1 inhibitors by methylome profiling identifies unique signature of 5-aza-2'deoxycytidine.
Mackin SJ; O'Neill KM; Walsh CP
Epigenomics; 2018 Aug; 10(8):1085-1101. PubMed ID: 30070602
[TBL] [Abstract][Full Text] [Related]
20. Demethylation by 5-aza-2'-deoxycytidine (5-azadC) of p16INK4A gene results in downregulation of vascular endothelial growth factor expression in human lung cancer cell lines.
Miki K; Shimizu E; Yano S; Tani K; Sone S
Oncol Res; 2001; 12(8):335-42. PubMed ID: 11589304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
